SAU:4015'
s ROE % Range Over the Past 10 Years
Min: 14 Med: 19.93 Max: 28.92
Current: 28.52
During the past 6 years, Jamjoom Pharmaceuticals Factory Co's highest ROE % was 28.92%. The lowest was 14.00%. And the median was 19.93%.
SAU:4015's ROE % is ranked better than 93.47% of 934
companies
in the Drug Manufacturers industry
Industry Median: 6.02
vs SAU:4015: 28.52
Jamjoom Pharmaceuticals Factory Co (SAU:4015) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Jamjoom Pharmaceuticals Factory Co ROE % Related Terms
Jamjoom Pharmaceuticals Factory Co ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jamjoom Pharmaceuticals Factory Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jamjoom Pharmaceuticals Factory Co ROE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jamjoom Pharmaceuticals Factory Co's ROE % distribution charts can be found below:
* The bar in red indicates where Jamjoom Pharmaceuticals Factory Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Jamjoom Pharmaceuticals Factory Co (SAU:4015) has a ROE % of 39.05% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. This is 96% above median its historical median of 19.93. Over the past decade, Jamjoom Pharmaceuticals Factory Co's ROE % has ranged from 14.00 to 28.92. According to the industry distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #61 out of 934 companies in the Drug Manufacturers industry, placing it in the top 6.5%.
Is Jamjoom Pharmaceuticals Factory Co's ROE % too high?
Jamjoom Pharmaceuticals Factory Co's current ROE % of 39.05% is 96% above median its 10-year median of 19.93. Over the past 10 years, this metric has ranged from a low of 14.00 to a high of 28.92. The Drug Manufacturers industry median ROE % is 6.02. Jamjoom Pharmaceuticals Factory Co's value of 39.05% is 548.7% above this industry median. Based on the distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #61 out of 934 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jamjoom Pharmaceuticals Factory Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jamjoom Pharmaceuticals Factory Co's ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jamjoom Pharmaceuticals Factory Co ranks #61 out of 934 companies for ROE %. This places Jamjoom Pharmaceuticals Factory Co in the top 7% of its industry — outperforming the majority of peers. The industry median ROE % is 6.02. Jamjoom Pharmaceuticals Factory Co's value of 39.05% is 548.7% above this benchmark. Historically, Jamjoom Pharmaceuticals Factory Co's own ROE % has ranged from 14.00 to 28.92 over the past decade. While the company's 10-year median is 19.93 vs. the industry median of 6.02, Jamjoom Pharmaceuticals Factory Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.02, based on 934 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jamjoom Pharmaceuticals Factory Co's current ROE % of 39.05% is 548.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Jamjoom Pharmaceuticals Factory Co and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jamjoom Pharmaceuticals Factory Co's current ROE % is 39.05%, which is 96% above median its own 10-year median of 19.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jamjoom Pharmaceuticals Factory Co stock overvalued right now?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co (SAU:4015) is currently considered Modestly Undervalued. The stock's GF Value™ is ﷼181.77, compared to a current price of ﷼157.00 — trading 13.6% below its estimated fair value. The current ROE % is 39.05%, which is 96% above median its 10-year median of 19.93 and 548.7% above the Drug Manufacturers industry median of 6.02. Jamjoom Pharmaceuticals Factory Co's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Jamjoom Pharmaceuticals Factory Co (SAU:4015), the current ROE % is 39.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jamjoom Pharmaceuticals Factory Co (SAU:4015) Overvalued in 2026?
Based on GuruFocus' analysis, Jamjoom Pharmaceuticals Factory Co stock appears to be undervalued.
The current stock price of ﷼157.00 is trading 13.6% below its estimated GF Value™ of ﷼181.77.
GuruFocus considers Jamjoom Pharmaceuticals Factory Co to be Modestly Undervalued.
Key valuation signals for SAU:4015:
ROE %: 39.05% (96% above median its 10-year median of 19.93)
GF Value™: ﷼181.77 vs. price of ﷼157.00 (13.6% below fair value)
Industry Position: 548.7% above the Drug Manufacturers median (#61 of 934)
No single metric tells the full story. See the SAU:4015 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jamjoom Pharmaceuticals Factory Co Business Description
Jamjoom Pharmaceuticals Factory Co is engaged in producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
73GF Score
Get the complete analysis for SAU:4015
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4015 has been successfully added to your 
